Stocks and InvestingStocks and Investing
Fri, October 16, 2020
Thu, October 15, 2020
Wed, October 14, 2020
Tue, October 13, 2020

Matthew Harrison Maintained (ADCT) at Buy with Decreased Target to $52 on, Oct 13th, 2020


Published on 2024-10-27 14:21:05 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Decreased Target from $53 to $52 on, Oct 13th, 2020.

Matthew, nor any peers, have made any analyst calls on ADCT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30